An inflammatory drug prospect
- 1 November 2001
- journal article
- Published by Springer Nature in Nature
- Vol. 414 (6860) , 159-160
- https://doi.org/10.1038/35102656
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activityNature, 2001
- Inflammation and Alzheimer's diseaseThe Lancet, 2001
- Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's DiseaseJournal of Neuroscience, 2000
- Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1Nature, 2000
- A randomized controlled trial of prednisone in Alzheimer’s diseaseNeurology, 2000
- Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouseNature, 1999
- A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domainNature, 1999
- Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's diseaseNature Medicine, 1996
- Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's diseaseNeurology, 1996
- THE ROLE OF ANTI-INFLAMMATORY DRUGS IN THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASEAnnual Review of Medicine, 1996